2023
P169 Treatment effects of ixekizumab and adalimumab at the individual digit level with nail and distal interphalangeal joint involvement in patients with psoriatic arthritis
McGonagle D, Kavanaugh A, McInnes I, Kristensen L, Merola J, Strober B, Lisse J, Pustizzi J, Sapin C, Bolce R, Ritchlin C. P169 Treatment effects of ixekizumab and adalimumab at the individual digit level with nail and distal interphalangeal joint involvement in patients with psoriatic arthritis. Rheumatology 2023, 62 DOI: 10.1093/rheumatology/kead104.210.Peer-Reviewed Original ResearchNail Psoriasis Severity IndexProportion of patientsPsoriatic arthritisWeek 24Nail diseaseNail involvementDIP involvementSanofi GenzymeWeek 52Total scoreEli LillyExact testNail bedUCB PharmaDistal interphalangeal (DIP) joint diseaseDistal interphalangeal joint involvementDifferent biological therapiesInterphalangeal joint involvementNail matrix involvementPsoriatic nail diseasePost-baseline assessmentPsoriasis Severity IndexNHS Greater GlasgowFisher's exact testTotal maximum score
2022
AB0924 Individual Digit Level Nail Involvement and Joint Assessment in Patients with Nail Psoriasis
Ritchlin C, Kristensen L, Strober B, Kavanaugh A, Bolce R, Lisse J, Pustizzi J, Somani N, Sapin C, Merola J. AB0924 Individual Digit Level Nail Involvement and Joint Assessment in Patients with Nail Psoriasis. Annals Of The Rheumatic Diseases 2022, 81: 1590.3-1591. DOI: 10.1136/annrheumdis-2022-eular.711.Peer-Reviewed Original ResearchNail Psoriasis Severity IndexNail involvementDIP jointJoint involvementSanofi GenzymeNail psoriasisInterphalangeal jointJoint diseaseEli LillyExact testAssessor-blinded studyDIP joint involvementJoint count scoresSpeakers bureauPsoriasis Severity IndexProximal interphalangeal jointsDistal interphalangeal jointMetacarpophalangeal joint levelFisher's exact testGrant/research supportChi-square testImportant clinical parametersJoint assessmentNail assessmentPsoriasis Registry
2021
Effect of baseline disease severity on achievement of treatment target with apremilast: results from a pooled analysis
Reich K, Mrowietz U, Menter A, Griffiths C, Bagel J, Strober B, Gomez N, Shi R, Guerette B, Lebwohl M. Effect of baseline disease severity on achievement of treatment target with apremilast: results from a pooled analysis. Journal Of The European Academy Of Dermatology And Venereology 2021, 35: 2409-2414. PMID: 34255891, DOI: 10.1111/jdv.17520.Peer-Reviewed Original ResearchConceptsDermatology Life Quality IndexWeek 32Treatment targetsPooled analysisNail Psoriasis Severity IndexGlobal assessmentPhysician global assessmentSevere plaque psoriasisBaseline disease severitySeverity IndexPsoriasis Severity IndexLong-term outcomesLife Quality IndexSevere skin diseaseImportant clinical conceptsESTEEM 1Plaque psoriasisDisease durationMost patientsPsoriasis AreaModerate diseasePsoriasis severityDisease characteristicsPsoriasis guidelinesSubgroup analysis